Fig 1.
Flow diagram of participant recruitment, screening, enrollment into SiVET study and assessment of willingness to participate in future HIV vaccine trials.
M = MSM, F = FSW.
Table 1.
Characteristics of 214 participants enrolled in a simulated HIV vaccine trial in Nairobi and the proportion willing to enroll in a future HIV vaccine trial, Nairobi, Kenya; Sep 2015-Sep 2018.
Table 2.
Predictors of willingness to participate in future HIV vaccine trial among the 214 participants in a simulated vaccine trial.
Table 3.
Motivating factors for future participation in HIV Vaccine trials among 174 SiVET participants reporting willingness to participate.